September 5, 2019 8:52am
The past sector gravity pulls have been a b---- (redacted), lately
As the sector is set gains amid after being undervalued and oversold
Show me the upside with at least some sustainability for the period it lasts
News: Ultragenyx Pharmaceutical (RARE) and partner GeneTx Biotherapeutics LLC were granted by the FDA: Orphan Drug and Rare Pediatric Disease designations to GTX-102 for the treatment of Angelman Syndrome, which is a serious, debilitating rare neurogenetic disorder.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.
RMi provides the realities of volatility and share pricing in the sector. That’s why the term “quantamental,” a blend of the two styles, may soon become common parlance among investors and traders.
Dow futures are UP +0.98% (+259 points), S&P futures are +0.94% (+28 points) and NASDAQ futures are +1.23% (+95 points)
U.S. stock index futures rallied Thursday after the U.S. and China agreed to meet next month in Washington to discuss trade;
European stocks higher on global trade and political reprieve with the pan-European Stoxx 600 rose 0.6% by mid-morning having earlier hit a one-month high;
- However, British Prime Minister Boris Johnson on Wednesday night failed in his bid to call a snap general election for October 15. A bill introduced by opposition parties to block Johnson from taking the U.K. out of the European Union without a deal on October 31 was also passed and will not ascend to the House of Lords, the upper chamber of parliament.
Asia Pacific equities are surging and the MSCI Asia ex-Japan index gained 0.84%; as Hong Kong stocks held to gains after seeing a 4% surge yesterday earlier, on the back of news that the city’s controversial extradition bill that’s sparked protests will be withdrawn.
Data docket: The private sector ADP National Employment Report for August will be released at 8:15 a.m. ET, with the latest weekly jobless claims and second-quarter productivity and unit labor costs set to be released slightly later in the session. A final reading of services Purchasing Managers’ Index (PMI) for August, ISM non-manufacturing data for August, and factory orders for July will also be released early Thursday.
Bles us traders, for these thy upside gifts which we are about to recieve ...
China’s Commerce Ministry issued a statement Thursday morning saying that Liu He, Beijing’s top negotiator on trade, had spoken with U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin <CNBC>.
From Wednesday’s evening post, “from a negative open to a positive close; back from the bottom with low volume.”
• The NASDAQ was up +102.72 or -1.30% to 7,976.88;
• The IBB closed up +0.06% and the XBI also closed up +0.51% after Tuesday’s IBB closed down -1.67% while the XBI also closed down -1.81%
• The close was positive with an A/D Line of 22/20 and 1 flat and 2 acquired;
• The range of the 22 upside was +0.21% (IONS) to +9.24% (ADVM) while the 20 downside ranged from -0.10% (SGMO) to -12.15% (RARE);
• 2 out of the 22 upside had higher than the 3 month average volume;
• 7 out of the 20 downside had higher than the 3 month average volume;
Q3/19 to date:
- In July, there were 9 positive, 1 holiday and 13 negative closes;
- In August there had been 12 negative and 10 positive closes
- September started with 1 positive, 1 holiday and 1 negative close
Companies in my headlights – It’s your decision; I provide an idea and context:
*** Let the machines and algorithms do the work for our portfolio, I would NOT … CHASE anything; go with the flow! ***
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.